Heartflow, Inc.
HTFL
47 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 17 4:51 PM | Rogers Campbell | Proposed Sale | 9,219 | $41.23 | $380.1K | — | View → |
| Aug 14, 2026 | Aug 14 8:58 PM | Cohen Arthur Bruce | Proposed Sale | 200,000 | $42.17 | $8.4M | — | View → |
| Aug 14, 2026 | Aug 14 7:29 PM | Healey Joseph Patrick | Proposed Sale | 150,000 | $41.50 | $6.2M | — | View → |
| Aug 14, 2026 | Aug 14 4:35 PM | Farquhar John C.M. | Proposed Sale | 15,560 | $39.06 | $607.8K | — | View → |
| Aug 10, 2026 | Aug 12 9:07 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 22,562 | $28.31 | $638.7K | 436,280(D) | View → |
| Aug 10, 2026 | Aug 10 5:00 PM | Farquhar John C.M. | Proposed Sale | 22,562 | $28.31 | $638.7K | — | View → |
| Jul 15, 2026 | Jul 17 9:54 PM | Campbell RogersChief Medical Officer | Sale | 9,219 | $25.72 | $237.1K | 88,731(D) | View → |
| Jul 15, 2026 | Jul 15 2:05 PM | Rogers Campbell | Proposed Sale | 9,219 | $25.72 | $237.1K | — | View → |
| Jul 10, 2026 | Jul 14 12:25 AM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 22,562 | $27.75 | $626.1K | 435,373(D) | View → |
| Jul 10, 2026 | Jul 10 1:43 PM | Farquhar John C.M. | Proposed Sale | 22,562 | $27.75 | $626.1K | — | View → |
| Jun 24, 2026 | Jun 26 10:08 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 38,900 | $35.00 | $1.4M | 457,935(D) | View → |
| Jun 24, 2026 | Jun 24 2:38 PM | Farquhar John C.M. | Proposed Sale | 38,900 | $35.00 | $1.4M | — | View → |
| Jun 10, 2026 | Jun 12 10:55 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 22,562 | $28.50 | $643.0K | 496,835(D) | View → |
| Jun 10, 2026 | Jun 10 2:47 PM | Farquhar John C.M. | Proposed Sale | 22,562 | $28.50 | $643.0K | — | View → |
| May 18, 2026 | May 20 9:55 PM | Campbell RogersChief Medical Officer | Sale | 9,219 | $28.34 | $261.3K | 78,731(D) | View → |
| May 18, 2026 | May 18 3:48 PM | Rogers Campbell | Proposed Sale | 9,219 | $28.34 | $261.3K | — | View → |
| May 11, 2026 | May 13 10:23 PM | John C.M. FarquharDirector, Chief Executive Officer | Sale | 22,562 | $29.12 | $657.0K | 519,397(D) | View → |
| May 11, 2026 | May 11 2:20 PM | Farquhar John C.M. | Proposed Sale | 22,562 | $29.12 | $657.0K | — | View → |
| Apr 30, 2026 | May 1 12:46 AM | Bain Capital Life Sciences Investors, LLC10% Owner | Sale | 948,757 | $29.23 | $27.7M | 8,448,158(I) | View → |
| Apr 29, 2026 | May 1 12:46 AM | Bain Capital Life Sciences Investors, LLC10% Owner | Sale | 797,133 | $29.37 | $23.4M | 9,396,915(I) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 18 1:07 AM | Campbell RogersChief Medical Officer | Option Exercise | 67,016 | $8.33 | 208,527(D) | View → |
| Feb 6, 2026 | Feb 11 1:55 AM | Marie L. JonesChief Accounting Officer, VP | Grant/Award | 37,795 | $27.74 | 37,795(D) | View → |
| Feb 6, 2026 | Feb 11 1:24 AM | John C.M. FarquharDirector, Chief Executive Officer | Grant/Award | 321,259 | $27.74 | 321,259(D) | View → |
| Feb 6, 2026 | Feb 11 1:21 AM | Campbell RogersChief Medical Officer | Grant/Award | 94,488 | $27.74 | 94,488(D) | View → |
| Feb 6, 2026 | Feb 11 1:18 AM | Vikram VergheseChief Financial Officer | Grant/Award | 119,685 | $27.74 | 119,685(D) | View → |
← Previous
Page 2 of 2